The overarching goal of this Program Project proposal is to discover naturally products from diverse natural sources that can serve as anticancer drug leads. Project 2, located at the College of Pharmacy, University of Illinois at Chicago (UIC), is comprised of botanical, chemical and biological elements. The primary goals for Project 2 are the discovery of new lead anticancer compound candidates from cyanobacteria and providing tropical plant material for Project 1, housed at The Ohio State University (OSU). The underlying hypothesis for Project 2 is that the diverse natural product structures from cultured non-marine cyanobacteria and tropical plants will be a rich source for anticancer leads. To achieve the stated goals the specific aims for Project 2 are as follows: 1) to obtain, culture, extract, and prepare fractions of cyanobacterial strains. We will obtain 100 non-marine cyanobacterial strains per year. The strain collection will focus on samples collected in the continental U.S. Each strain will be cultured, extracted and prefractionated. The resulting fractions (-700 fractions/year) will be submitted for biological evaluation in the biological test systems available at Core A, Projects 1 and 3 as well as our pharmaceutical partner, Eisai. 2) to isolate and determine the structures of the active cyanobacterial metabolites. Fractions showing promising activity in the biological test systems will be analyzed by LC-MS-NMR to identify any known active compounds (dereplication). Active fractions expected to contain novel metabolites will be fractionated using assay guided fractionation to obtain pure natural product(s). Isolates will be structurally defined using microscale NMR and MS methodologies. Structurally-characterized compounds will be submitted for extensive evaluation in the biological test systems available in Core A, Projects 1 and 3 as well as our pharmaceutical partner, Eisai Research institute. In addition. Core B will perform chemical optimization and modifications of prioritized compounds. We will re-isolate larger amounts of any candidate compounds for further evaluation. 3) To acquire all plant materials that will be required by the proposed Program Project We will provide 300 fully documented plant samples per year to Project 1 for extraction and biologica evaluation. We will also re-collect plant materials for larger scale isolation, as needed.
; The primary purpose of Project 2 of this program project is to discover new cancer chemotherapeutic leads from cyanobacteria and to supply plants from tropical rainforests for further investigation in Project 1. The proposed research will impact human health by creating new lead compounds for the development of drugs to treat cancer. Some of the compounds discovered may work by new mechanism of action, thus increasing our understanding how to treat this disease.
|Crnkovic, Camila M; Krunic, Aleksej; May, Daniel S et al. (2018) Calothrixamides A and B from the Cultured Cyanobacterium Calothrix sp. UIC 10520. J Nat Prod 81:2083-2090|
|Wilson, Tyler A; Tokarski 2nd, Robert J; Sullivan, Peter et al. (2018) Total Synthesis of Scytonemide A Employing Weinreb AM Solid-Phase Resin. J Nat Prod 81:534-542|
|Lu, Chunwan; Yang, Dafeng; Sabbatini, Maria E et al. (2018) Contrasting roles of H3K4me3 and H3K9me3 in regulation of apoptosis and gemcitabine resistance in human pancreatic cancer cells. BMC Cancer 18:149|
|El-Elimat, Tamam; Rivera-Chávez, José; Burdette, Joanna E et al. (2018) Cytotoxic homoisoflavonoids from the bulbs of Bellevalia flexuosa. Fitoterapia 127:201-206|
|Ren, Yulin; Anaya-Eugenio, Gerardo D; Czarnecki, Austin A et al. (2018) Cytotoxic and NF-?B and mitochondrial transmembrane potential inhibitory pentacyclic triterpenoids from Syzygium corticosum and their semi-synthetic derivatives. Bioorg Med Chem 26:4452-4460|
|Crnkovic, Camila M; May, Daniel S; Orjala, Jimmy (2018) The impact of culture conditions on growth and metabolomic profiles of freshwater cyanobacteria. J Appl Phycol 30:375-384|
|Woodard, John L; Huntsman, Andrew C; Patel, Pratiq A et al. (2018) Synthesis and antiproliferative activity of derivatives of the phyllanthusmin class of arylnaphthalene lignan lactones. Bioorg Med Chem 26:2354-2364|
|Ren, Yulin; Gallucci, Judith C; Li, Xinxin et al. (2018) Crystal Structures and Human Leukemia Cell Apoptosis Inducible Activities of Parthenolide Analogues Isolated from Piptocoma rufescens. J Nat Prod 81:554-561|
|May, Daniel S; Kang, Hahk-Soo; Santarsiero, Bernard D et al. (2018) Ribocyclophanes A-E, Glycosylated Cyclophanes with Antiproliferative Activity from Two Cultured Terrestrial Cyanobacteria. J Nat Prod 81:572-578|
|Oblinger, Janet L; Burns, Sarah S; Huang, Jie et al. (2018) Overexpression of eIF4F components in meningiomas and suppression of meningioma cell growth by inhibiting translation initiation. Exp Neurol 299:299-307|
Showing the most recent 10 out of 144 publications